Drug Type Autologous CAR-T |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Lymphocytic Leukemia | Phase 2 | China | 01 Feb 2016 | |
B lymphoblastic leukemia lymphoma | Phase 2 | China | 01 Feb 2016 | |
Chronic lymphocytic leukaemia refractory | Phase 2 | China | 01 Feb 2016 | |
Diffuse Large B-Cell Lymphoma | Phase 2 | China | 01 Feb 2016 | |
Mantle cell lymphoma recurrent | Phase 2 | China | 01 Feb 2016 | |
Recurrent Grade 3a Follicular Lymphoma | Phase 2 | China | 01 Feb 2016 |